四肢骨折手术治疗后疼痛缓解:非劣效性随机对照试验
这项在荷兰一级创伤中心进行的2周随访非劣效性随机对照试验纳入52例单侧四肢骨折患者,随机接受按需标准剂量的第一步药物(对乙酰氨基酚)或第二步药物(对乙酰氨基酚联合曲马多)。主要结局为11点量表自报疼痛缓解满意度,第一步组均值为8.3,第二步组为8.5,均值差0.2分(95%CI -0.78至1.30),未超过2.0分非劣效界值,表明第一步药物不劣于第二步药物。
要点
- 52例单侧四肢骨折术后患者随机接受对乙酰氨基酚或对乙酰氨基酚联合曲马多,按需标准剂量给药。
- 疼痛缓解满意度均值第一步组8.3 vs 第二步组8.5,均值差0.2分(95%CI -0.78至1.30),未超过2.0分非劣效界值。
- 符合方案分析结果相似:均值差0.2分(95%CI -1.03至1.57)。
核心结论
- 本研究提供证据提示,对四肢骨折手术治疗后患者,处方对乙酰氨基酚的疼痛缓解不劣于对乙酰氨基酚联合曲马多。
- 鉴于曲马多副作用更多且可能成瘾,作者认为对乙酰氨基酚应被视为四肢骨折术后疼痛缓解的主要药物。
研究设计与样本
- 2周随访的非劣效性随机对照试验,2012年7月至2015年3月在荷兰一家一级创伤中心纳入52例单侧四肢骨折患者。
- 患者出院时随机分配接受按需标准剂量的第一步药物(对乙酰氨基酚)或第二步药物(对乙酰氨基酚联合曲马多)。
- 进行意向性治疗分析和符合方案分析,主要结局为11点序数量表自报疼痛缓解满意度,检验假设在数据收集前制定。
主要发现
- 共52例患者进行分析,基线特征均衡,第一步组27例,第二步组25例。
- 疼痛管理满意度均值第一步组8.3 vs 第二步组8.5,均值差0.2分(95%CI -0.78至1.30),未超过2.0分非劣效界值,表明第一步不劣于第二步。
- 符合方案分析结果相似:均值差0.2分(95%CI -1.03至1.57)。
关键数值与推荐
- 非劣效界值为2.0分(11点序数量表疼痛缓解满意度)。
- 主要结局均值差0.2分(95%CI -0.78至1.30)未超过非劣效界值2.0分。
- 符合方案分析均值差0.2分(95%CI -1.03至1.57)。
- 证据等级:治疗性I级。
临床怎么用
- 作者认为对乙酰氨基酚应被视为四肢骨折术后疼痛缓解的主要药物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Opioid pain medication is frequently given to patients recovering from a surgical procedure for an extremity fracture in spite of evidence that acetaminophen may be adequate. The aim of this study was to determine whether prescription of step 1 pain medication (acetaminophen) is noninferior to step 2 pain medication (acetaminophen and tramadol) after operative treatment of an extremity fracture. METHODS: Fifty-two patients with a single extremity fracture were randomized from July 2012 to March 2015 in this 2-week follow-up, noninferiority trial in a level-I trauma center in the Netherlands. Patients were randomly assigned to receive step 1 (acetaminophen) or step 2 (acetaminophen and tramadol) medication in standard doses on an as-needed basis on discharge. Intention-to-treat and per-protocol analyses were conducted. The primary outcome was self-reported satisfaction with pain relief measured on an 11-point ordinal scale. The hypothesis being tested was formulated before the collection of data. The mean differences between the groups were reported for intention-to-treat and per-protocol analyses. RESULTS: A total of 52 patients, with equal baseline characteristics, were analyzed in this study; the step 1 group consisted of 27 subjects and the step 2 group consisted of 25 subjects. The mean satisfaction with pain management was 8.3 for step 1 and 8.5 for step 2 medications. This mean difference of 0.2 point (95% confidence interval [CI], -0.78 to 1.30 points) did not exceed the noninferiority margin of 2.0 points, indicating that step 1 was noninferior to step 2. A similar result was found in the per-protocol analysis (mean difference, 0.2 point [95% CI, -1.03 to 1.57 points]). CONCLUSIONS: This study offers evidence to suggest that prescription of acetaminophen is not inferior compared with acetaminophen and tramadol in patients who underwent operative treatment for an extremity fracture. Given that tramadol has more side effects and is potentially habit-forming, acetaminophen should be considered the mainstay for pain relief in patients recovering from extremity fracture surgical procedures. LEVEL OF EVIDENCE: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
引用
- Helmerhorst GTT, Zwiers R, Ring D, et al. Pain Relief After Operative Treatment of an Extremity Fracture: A Noninferiority Randomized Controlled Trial. J Bone Joint Surg Am. 2017. PMID: 29135664. doi:10.2106/JBJS.17.00149
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。